As reps we are typically given a week to review a study, memorize s talk track and given a half dozen defensive propositions to spew back to the unbelievers. On our own detail aids, we even discuss personal satisfaction. Yet over the years, I have seen drs face life threatening aes with products I sold, including one in which 3 researchers were indicted for suppressing aes in a clinical trial for a drug removed from the market 3 years earlier for a clinically significant number of these exact events. To say we speak with authority with the aid of one or two clinical trials is to be full if oneself. When drs can elicit the response of their pts who compared both meds, then they really have a fair view in my mind. I will encourage the drs to do this to spur new use and hope that it is successful. You try pants on before you buy them, dont you? So what's the difference here. Our drs are doing the thing we can't, compare two meds in the same pt and guage direct results. Most drs know 5 pts won't do, but once a clear pattern emerges over 10 or more pts, the Dr is not beholden by anything else other than common sense.
Don't think too much of yourself. Did you study organic chemistry? Are you an RN, NP, PA, DO, MD, RPh? Oh, you stayed at Holiday Inn Express last night? Most clinicians are far smarter and discerning than you can even imagine. Hell, I still take ibuprofen because Zorvolex really just aint that good. Maybe it's just me, but I'm pretty sure its not. Trust me, I'm looking for the next job already, hopefully somewhere where I really am making a difference.